Sensei Biotherapeutics Appoints New Financial Chief
Company Announcements

Sensei Biotherapeutics Appoints New Financial Chief

Sensei Biotherapeutics ( (SNSE) ) just unveiled an announcement.

Sensei Biotherapeutics, Inc. recently appointed Josiah Craver as their new principal financial officer and principal accounting officer. Craver, bringing in a wealth of experience from KALA BIO and Solid Biosciences, is set to receive a $360,000 base salary, with a 35% annual bonus target and an option to purchase 80,000 company shares. His employment package includes financial safeguards such as a six-month base salary as severance and COBRA reimbursements, with additional benefits in the event of termination following a company change in control. This strategic move aims to bolster the financial leadership within Sensei Biotherapeutics, signaling potential growth and stability for investors.

Learn more about SNSE stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySensei Biotherapeutics reports Q3 EPS (29c), consensus (32c)
Ryan AdistSNSE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App